H%)!MFOB.E)1:^ATA8<#?Z-K#8AD
SYSTEM PROCESSING...
H%)!MFOB.E)1:^ATA8<#?Z-K#8AD
SYSTEM PROCESSING...
Posted: 2025-05-11 12:22:34 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-11 12:22:41 UTC
Verified By
Rollup News
The article discusses the conflict between pharmaceutical companies' profit motives and the development of cures for diseases, using Gilead Sciences' Hepatitis C cure as an example where profits decreased significantly after a cure was introduced.
Pharmaceutical companies prioritize revenue over curing chronic illnesses.
Cures can negatively impact the long-term profits of pharmaceutical companies.
The focus on temporary solutions maintains cash flow for Big Pharma.
Balancing the need for profit with the desire to cure diseases.
The potential for decreased revenue following the introduction of a cure.
The focus on temporary solutions rather than addressing the root causes of chronic illnesses.